Follow-up of infants with congenital toxoplasmosis detected by polymerase chain reaction analysis of amniotic fluid

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 17, Issue 12, 1998, Pages 853-858

  Gratzl, R ^a   Hayde, M ^a   Kohlhauser, C ^a   Hermon, M ^a   Burda, G ^a   Strobl, W ^b   Pollak, A ^a  

^a ST ANNA CHILDREN S HOSPITAL   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PYRIMETHAMINE; SPIRAMYCIN; SULFADIAZINE;

ADULT; AMNION FLUID ANALYSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGENITAL TOXOPLASMOSIS; DNA DETERMINATION; FEMALE; FETUS; FETUS DEATH; FETUS DISEASE; FETUS OUTCOME; FOLLOW UP; HUMAN; HUMAN CELL; INFANT; MALE; POLYMERASE CHAIN REACTION; PREGNANCY; PRENATAL CARE; PRIORITY JOURNAL; PSYCHOMOTOR DEVELOPMENT; SERODIAGNOSIS; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ADULT; AMNIOTIC FLUID; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIPROTOZOAL AGENTS; DNA, PROTOZOAN; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PRENATAL DIAGNOSIS; PROSPECTIVE STUDIES; PYRIMETHAMINE; REPRODUCIBILITY OF RESULTS; SPIRAMYCIN; SULFADIAZINE; TOXOPLASMA; TOXOPLASMOSIS; TOXOPLASMOSIS, CONGENITAL;

EID: 0032425830     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100960050206     Document Type: Article

References (20)

1. 1. Koppe JG, Loewer-Sieger DH, de-Roever-Bonnet H: Results of 20-years follow-up of congenital toxoplasmosis. Lancet (1986) i:254-256
2. 2. Wilson CB, Remington JS, Stagno S, Reynolds DW: Development of adverse sequelae in children born with subclinical Toxoplasma infection. Pediatrics (1980) 66:767-774
3. 3. McAuley J, Boyer KM, Patel D, Mets M, Swisher C, Roizen N, Wolters C, Stein L, Stein M, Schey W, Remington J, Meier P, Johnson D, Heydeman P, Holfels E, Withers S, Mack D, Brown C, Patton D, McLeod R: Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago collaborative treatment trial. Clinical Infectious Diseases (1994) 18:38-72
4. 4. Roizen N, Swisher CN, Stein MA, Hopkins J, Boyer KM, Holfels E, Mets MB, Stein L, Patel D, Meier P, Withers S, Remington J, Mack D, Heydeman P, Patton D, McLeod R: Neurologic and developmental outcome in treated congenital toxoplasmosis. Pediatrics (1995) 95:11-20
5. 5. Remington JS, McLeod R, Desmonts G: Toxoplasmosis. In: Remington JS, Klein JO (eds): Infectious diseases of the fetus and the newborn infant. W.B. Saunders, Philadelphia (1995) pp. 140-267
6. 6. Lebech M, Joynson DH, Seitz HM, Thulliez P, Gilbert RE, Dutton GN, Olivsen B, Petersen E: Classification system and case definitions of Toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring. European Journal of Clinical Microbiology & Infectious Diseases (1996) 15:799-805
7. 7. Ho-Yen D, Joss A: Human toxoplasmosis. Oxford University Press, New York (1992) pp. 56-183
8. 8. Burg JL, Grover CM, Pouletty P, Boothroyd JC: Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction. Journal of Clinical Microbiology (1989) 27:1787-1792
9. 9. Grover CM, Thulliez P, Remington JS, Boothroyd JC: Rapid prenatal diagnosis of congenital Toxoplasma infection by using polymerase chain reaction and amniotic fluid. Journal of Clinical Microbiology (1990) 28:2297-2301
10. 10. Dupouy-Camet J, Bougnoux ME, Lavareda de Souza S, Thulliez P, Dommergues M, Mandelbrot L, Ancelle T, Tourte-Schaefer C, Benarous R: Comparative value of polymerase chain reaction and conventional biological test for the prenatal diagnosis of congenital toxoplasmosis. Annales de Biologie Clinique (1992) 50:315-319
11. 11. Hohlfeld P, Daffos F, Costa JM, Thulliez P, Forestier F, Vidaud M: Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain-reaction test on amniotic fluid. New England Journal of Medicine (1994) 331:695-699
12. 12. Aspöck H, Pollak A: Prevention of prenatal toxoplasmosis by serological screening of pregnant women in Austria. Scandinavian Journal of Infectious Diseases (1992) Supplement 84:32-37
13. 13. Sabin AB, Feldman HA: Dyes as microchemical indicators of a new immunity phenomenon affecting a protozoan parasite (Toxoplasma). Science (1948) 108:660-663
14. 14. Desmonts G, Naot Y, Remington JS: Immunglobulin M -immunosorbent assay for diagnosis of infectious diseases: diagnosis of acute congenital and acquired Toxoplasma infections. Journal of Clinical Microbiology (1981) 14:486-491
15. 15. Takahshi E, Rossi C: Use of three immunological techniques for the detection of Toxoplasma spIgA antibodies in acute toxoplasmosis. Journal of Clinical Pathology (1994) 47:1101-1104
16. 16. Knerer B, Hayde M, Gratz G, Bernaschek G, Strobl W, Pollak A: Direkter Nachweis von Toxoplasma gondii mit Polymerase-Kettenreaktion zur Diagnostik einer fetalen Toxoplasma-Infektion. Wiener Klinische Wochenschrift (1995) 107:137-140
17. 17. Longo MC, Berninger MS, Hartley JL: Use of uracil DNA glycosylase to control carryover contamination in polymerase chain reactions. Gene (1990) 93:125-128
18. 18. Bessieres MH, Roques C, Berrebi A, Barre V, Cazaux M, Seguela JP: IgA antibody response during aquired congenital toxoplasmosis. Journal of Clinical Pathology (1992) 45:605-608
19. 19. Couvreur J, Desmonts G, Thulliez P: Prophylaxis of congenital toxoplasmosis. Effects of spiramycin on placental infection. Journal of Antimicrobial Chemotherapy (1988) 22, Supplement B:193-200
20. 20. Stranc LC, Evans JA, Hamerton JL: Chorionic villus sampling and amniocentesis for prenatal diagnosis. Lancet (1997) 349:711-714